Volta Medical SAS

Volta Medical conclut un accord de développement conjoint avec GE HealthCare afin d’améliorer les procédures d’arythmies grâce à des technologies d’électrophysiologie basées sur l’IA

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Enhance Arrhythmia Procedures with AI-Driven Electrophysiology Technologies

Volta Medical présente les résultats du premier essai transatlantique contrôlé et randomisé comparant l’ablation assistée par l’IA au traitement conventionnel pour la fibrillation atriale persistante

Volta Medical presents results from first transatlantic randomized controlled trial comparing AI-assisted ablation procedure with conventional treatment for persistent atrial fibrillation patients

Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation

Volta Medical Announces Late-Breaking TAILORED-AF Randomized Clinical Trial Results at Heart Rhythm 2024 in Boston, MA, USA